Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

Ledermann, J. A., Embleton-Thirsk, A. C., Perren, T. J., Jayson, G. C., Rustin, G. J. S., Kaye, S. B., Hirte, H., Oza, A., Vaughan, M., Friedlander, M., González-Martín, A., Deane, E., Popoola, B., Farrelly, L., Swart, A. M., Kaplan, R. S. and Parmar, M. K. B. (2021) Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial. ESMO Open, 6 (2). ISSN 2059-7029

[img]
Preview
PDF (Published_Version) - Published Version
Available under License Creative Commons Attribution.

Download (396kB) | Preview
Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 27 Mar 2021 00:49
Last Modified: 07 Apr 2021 01:40
URI: https://ueaeprints.uea.ac.uk/id/eprint/79569
DOI: 10.1016/j.esmoop.2020.100043

Actions (login required)

View Item View Item